Therapy Areas: Oncology
FDA accepts Genentech's giredestrant application for early-stage breast cancer
2 June 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), said on Tuesday that the US Food and Drug Administration (FDA) has accepted its New Drug Appli...
Amgen receives EU marketing authorisation for IMDYLLTRA in ES-SCLC
2 June 2026 - US biopharmaceutical company Amgen (NASDAQ:AMGN) announced on Monday that it has received marketing authorisation from the European Commission for IMDYLLTRA (tarlatamab) as a monotherapy...
Anixa secures Canadian patent milestone for ovarian cancer vaccine
1 June 2026 - Biotechnology company Anixa Biosciences Inc (NASDAQ: ANIX) reported on Monday that it has received a Notice of Allowance from the Canadian Intellectual Property Office for a patent cover...
Rallybio and Avenzo Therapeutics announce merger agreement and USD215m financing
1 June 2026 - Clinical-stage biotechnology companies Rallybio Corporation (Nasdaq:RLYB) and Avenzo Therapeutics Inc announced on Monday that they have entered into a definitive merger agreement under ...
IBA launches Cyclone iKure for industrial-scale Astatine-211 production
1 June 2026 - Particle accelerator technology company Ion Beam Applications S.A. (IBA) (Euronext Brussels:IBAB) announced on Monday the launch of Cyclone iKure, a dedicated cyclotron designed for rout...
Circio and GenAssist announce gene therapy research collaboration for muscle diseases and in vivo cell therapy
1 June 2026 - Biotechnology companie Circio Holding ASA (OSE:CRNA) and GenAssist Ltd announced on Monday that they have entered into a research collaboration to develop circVec-enhanced AAV vectors fo...